Atrial fibrillation and NOACs: The Lancet Haematology: April 2, 2015
The Lancet Haematology in conversation with - Un podcast de The Lancet Group
Catégories:
Mahmoud Zureik discusses risk of bleeding in patients with non-valvular atrial fibrillation who switched and those who remained on a vitamin K antagonist. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
